Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)

Clinical trial NCT05694819 · COMPLETED

Trial details

NCT number: NCT05694819
Sponsor: National Cancer Center Hospital East
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Salivary Gland Cancer

Start date: 2020-04-17
Primary completion: 2024-08-09
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.